2025
Public transport pricing: An evaluation of the 9-Euro ticket and an alternative policy proposal
Andor M, Dehos F, Gillingham K, Hansteen S, Tomberg L. Public transport pricing: An evaluation of the 9-Euro ticket and an alternative policy proposal. Economics Of Transportation 2025, 42: 100415. DOI: 10.1016/j.ecotra.2025.100415.Peer-Reviewed Original ResearchPublic transportIntroduction of dynamic pricingCar tripsHigher welfare gainsDynamic pricingAlternative policy proposalsWelfare effectsWelfare gainsEconomic theoryAlternative policiesPublic fundsPolicy proposalsPotential policiesEmpirical approachTransportPolicyTripsPriceCarEuroFundingWelfareCostEvidenceProphylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A : A Cost-Effectiveness Analysis.
Ito S, Potnis K, Harvey J, Sra M, Bewersdorf J, Bona R, Krumholz H, Cuker A, Pandya A, Goshua G. Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A : A Cost-Effectiveness Analysis. Annals Of Internal Medicine 2025, 178: 819-828. PMID: 40258278, PMCID: PMC12170149, DOI: 10.7326/annals-24-02749.Peer-Reviewed Original ResearchConceptsEquity weightsSevere hemophilia AInequality aversion parameterFactor VIIIHemophilia AAversion parameterCost-effectiveness analysisEquity standardsCost-effectiveness of prophylaxisTime horizonOnce-weekly prophylaxisPriceAnnualized bleeding rateIncremental cost-effectiveness ratioFactor VIII prophylaxisScenario analysisCost-effectiveness ratioUnited StatesLifetime QALYsBleeding rateProphylaxisNational Institutes of HealthCost-effectiveInstitutes of HealthAlfa
2024
OP09 Investigating The Nature And Scope Of Innovative Payment And Pricing Schemes For Health Technologies
Ardito V, Cavallaro L, Drummond M, Ciani O. OP09 Investigating The Nature And Scope Of Innovative Payment And Pricing Schemes For Health Technologies. International Journal Of Technology Assessment In Health Care 2024, 40: s5-s5. PMCID: PMC11719172, DOI: 10.1017/s0266462324000734.Peer-Reviewed Original ResearchHealth technology assessmentHealth technologiesWeb of ScienceNested evaluationInnovation paymentsSystematic reviewStudy protocolTechnology assessmentHealthImplementation challengesData collection needsAgency websitesExpenditure capsAffordability issuesPayment schemeProduct categoriesPricing schemeDistribution of riskCollection needsPricePROSPEROReimbursementHow is rooftop solar capitalized in home prices?
Gillingham K, Watten A. How is rooftop solar capitalized in home prices? Regional Science And Urban Economics 2024, 107: 104006. DOI: 10.1016/j.regsciurbeco.2024.104006.Peer-Reviewed Original ResearchHome valuesHome improvementHedonic modelHome pricesHousing marketDiscount ratePrice premiumEmpirical challengesLow capitalResidential solar installationsSolar homesCapitalRooftop solarPremiumPriceSolar installationsDiscountResidual valueInvestmentMarketUnited StatesTransactionsThird partyHousingHomeAdverse selection and network design under regulated plan prices: Evidence from Medicaid
Kreider A, Layton T, Shepard M, Wallace J. Adverse selection and network design under regulated plan prices: Evidence from Medicaid. Journal Of Health Economics 2024, 97: 102901. PMID: 38944945, PMCID: PMC11392643, DOI: 10.1016/j.jhealeco.2024.102901.Peer-Reviewed Original ResearchEconomic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis
Ryckman T, Schumacher S, Lienhardt C, Sweeney S, Dowdy D, Mirzayev F, Kendall E. Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis. The Lancet Global Health 2024, 12: e995-e1004. PMID: 38762299, PMCID: PMC11126367, DOI: 10.1016/s2214-109x(24)00088-3.Peer-Reviewed Original ResearchConceptsRifampin-resistant tuberculosisRifampin-susceptible tuberculosisMedium-term costsTuberculosis treatmentRifampin susceptibilityTuberculosis regimensStandard-of-care regimensCost-effective priceEstimated pricePrice thresholdsPriceDrug costsCost-neutralNovel drug combinationsStandard-of-careSouth AfricaTuberculosis treatment regimensEconomic implicationsStandard of carePatient-borne costsHigh-burden countriesCohort of adultsDecision-analytic modelShorter regimensNovel regimensAssessing the Progress toward a Water-Efficient Economy in the United States from 1985 to 2015
Du Y, Wang R, Zimmerman J. Assessing the Progress toward a Water-Efficient Economy in the United States from 1985 to 2015. Environmental Science And Technology 2024, 58: 8696-8708. PMID: 38717867, DOI: 10.1021/acs.est.3c09219.Peer-Reviewed Original ResearchConceptsAgricultural water use efficiencyWater use efficiencySustainable Development Goal 6Water priceEconomic growthTime series analysisUnited Nations Sustainable Development Goal 6Economic dataEquitable developmentAffluent statesWater withdrawalEffective water planningUS statesWater planningLocal communitiesWater utilitiesSeries analysisUS countiesGoal 6Increasing industrializationUse concernsUnited StatesNational trendsPriceCommunityThe Gender Wage Gap: Skills, Sorting, and Returns
Humphries J, Joensen J, Veramendi G. The Gender Wage Gap: Skills, Sorting, and Returns. AEA Papers And Proceedings 2024, 114: 259-264. DOI: 10.1257/pandp.20241026.Peer-Reviewed Original ResearchLessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications.
Nagel K, Ramachandran R, Lipska K. Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications. Diabetes Care 2024, 47: 1246-1256. PMID: 38536964, PMCID: PMC11272967, DOI: 10.2337/dci23-0042.Peer-Reviewed Original ResearchOut-of-pocket paymentsInflation ratePrice hikesPolicy prescriptionsPriceReduced priceHealth insuranceMarket entryPolicy evaluationDrug pricesGovernment negotiatorsBiosimilar competitionPharmacy benefit managersAnticompetitive practicesInflationFederal interventionIncreased enforcementPolicyInsulin pricesPublication productivityReduction ActFederal levelDrug manufacturersBenefit managersCompetitionMedicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data
Qureshi O, Ramachandran R, Ross J. Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data. Journal Of Pharmaceutical Policy And Practice 2024, 17: 2312374. PMID: 38434725, PMCID: PMC10906125, DOI: 10.1080/20523211.2024.2312374.Peer-Reviewed Original ResearchDrug spendingPrice negotiationsPrescription drug expendituresAnnual drug spendingInflation Reduction ActMedicare pricesSpending dataReduction ActMedicare spendingDrug expendituresSpendingDrug pricesCenters for Medicare & Medicaid ServicesMedicare Part BInflationPriceAnnual Medicare spendingEligibility requirementsMedicareNegotiationExpenditureDelivering affordable clean energy to consumers
Kopalle P, Burkhardt J, Gillingham K, Grewal L, Ordabayeva N. Delivering affordable clean energy to consumers. Journal Of The Academy Of Marketing Science 2024, 52: 1452-1474. DOI: 10.1007/s11747-024-01003-2.Peer-Reviewed Original ResearchConsumer responsesDynamic pricingConsumer surveyDynamic electricity pricesFlow of informationConsumersElectricity pricesSystem-wide solutionClean energyPriceResearch questionsBi-directional flow of informationMultimethod approachMultiple leversClean electricityFirmsMarketBi-directional flowAutomated solutionFrameworkAdoptionClean energy solutions
2023
Field Experimental Evidence on the Effect of Pricing on Residential Electricity Conservation
Burkhardt J, Gillingham K, Kopalle P. Field Experimental Evidence on the Effect of Pricing on Residential Electricity Conservation. Management Science 2023, 69: 7784-7798. DOI: 10.1287/mnsc.2020.02074.Peer-Reviewed Original ResearchEmission reductionField experimental evidenceGreenhouse gas emission reductionEffect of priceGas emission reductionWarm glowElectricity conservationMonetary incentivesEffort costsOnline appendixElectricity consumptionConsumer tradeoffsTexas householdsResidential consumersPriceElectric utilitiesAppliance-level dataGeneration costConsumersOff-peakLoad shiftingElectricityClimate changeIncentivesCostNonlinear responses of crude oil prices to the US dollar exchange rates: the role of inventories
Hu Z, Yan L. Nonlinear responses of crude oil prices to the US dollar exchange rates: the role of inventories. Empirical Economics 2023, 66: 1491-1510. DOI: 10.1007/s00181-023-02502-x.Peer-Reviewed Original ResearchUS dollar exchange rateCrude oil pricesDollar exchange rateOil pricesExchange rateExchange rate changesTime-varying relationshipDollar changePriceRate changesStorage theoryEconomic driversThreshold vectorAsymmetric mannerCrude oilMarket demandShockTheoretical evidenceSignificant influenceDemandInventoryRegimeDriversRelationshipRateHas Consumer Acceptance of Electric Vehicles Been Increasing? Evidence from Microdata on Every New Vehicle Sale in the United States
Gillingham K, van Benthem A, Weber S, Saafi M, He X. Has Consumer Acceptance of Electric Vehicles Been Increasing? Evidence from Microdata on Every New Vehicle Sale in the United States. AEA Papers And Proceedings 2023, 113: 329-335. DOI: 10.1257/pandp.20231065.Peer-Reviewed Original Research
2022
The order flow cost of index rolling in commodity futures markets
Irwin S, Sanders D, Yan L. The order flow cost of index rolling in commodity futures markets. Applied Economic Perspectives And Policy 2022, 45: 1025-1050. DOI: 10.1002/aepp.13297.Peer-Reviewed Original ResearchSunshine vs. predatory trading effects in commodity futures markets: New evidence from index rebalancing
Yan L, Irwin S, Sanders D. Sunshine vs. predatory trading effects in commodity futures markets: New evidence from index rebalancing. Journal Of Commodity Markets 2022, 26: 100195. DOI: 10.1016/j.jcomm.2021.100195.Peer-Reviewed Original ResearchCommodity futures marketsS&P GSCIFutures marketGoldman Sachs Commodity IndexCommodity futures pricesLong-short strategyCumulative abnormal returnsAnnual rebalancingCommodity indicesFutures pricesRebalancing periodsTrade effectsAbnormal returnsTrade theoryFinancial investorsS&PRebalancingCommodityGSCIInvestorsMarketPriceReturnImpactNext week
2021
Pricing indirect emissions accelerates low—carbon transition of US light vehicle sector
Wolfram P, Weber S, Gillingham K, Hertwich E. Pricing indirect emissions accelerates low—carbon transition of US light vehicle sector. Nature Communications 2021, 12: 7121. PMID: 34880225, PMCID: PMC8654946, DOI: 10.1038/s41467-021-27247-y.Peer-Reviewed Original ResearchSales of electric vehiclesAdoption of electric vehiclesElectric vehicle adoptionLight-vehicle sectorElectric vehiclesIndirect emissionsTransport policyVehicle adoptionVehicle sectorPricing emissionsReduce emissionsTechnological changeLow-carbon transitionCarbon priceReduce CO2 emissionsVehicleLife cycle assessmentPolicy scenariosAdoptionBattery productionCO2 emissionsCycle assessmentIntegrated energy modelSalesPriceSocial Learning and Solar Photovoltaic Adoption
Gillingham K, Bollinger B. Social Learning and Solar Photovoltaic Adoption. Management Science 2021, 67: 7091-7112. DOI: 10.1287/mnsc.2020.3840.Peer-Reviewed Original ResearchGroup priceAdoption of residential solar photovoltaic systemsLow-cost emission reductionsAdoption of prosocial behaviorsResidential solar photovoltaic systemsMatthew ShumSpur adoptionEmission reductionPriceGrowing literatureInformation campaignsIntervention showSocial learningProsocial behaviorInstallation priceAcquisition costsTreatment effectsShumMarketEconomyMunicipalitiesThe Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice
Varghese M, Liu C, Kazi D. The Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice. Current Cardiology Reports 2021, 23: 163. PMID: 34599393, PMCID: PMC8486158, DOI: 10.1007/s11886-021-01598-w.Peer-Reviewed Original ResearchConceptsOut-of-pocket costsIncreasing pharmaceutical spendingCost-related non-adherenceValue-based pricingCo-insurancePharmaceutical spendingCost-effectiveness analysisCo-paymentPricePrice of progressMarket entryDrug pricesMarketBipartisan supportLegislative progressCostCardiovascular drugsOrphan drugsSocietal perspectiveDiscountSpendingRebatesSectorConsumer Myopia in Vehicle Purchases: Evidence from a Natural Experiment
Gillingham K, Houde S, van Benthem A. Consumer Myopia in Vehicle Purchases: Evidence from a Natural Experiment. American Economic Journal Economic Policy 2021, 13: 207-238. DOI: 10.1257/pol.20200322.Peer-Reviewed Original ResearchFuel economy ratingsEconomy rateNatural experimentConsumer valuation of fuel economyFuel economy policyConsumer myopiaEquilibrium effectsConsumer valuationExogenous variationEconomy policiesPurchase priceVehicle purchaseFuel costConsumersPurchaseUndervaluationPriceFuel economyEconomyCostWillingnessVehiclePolicyEquilibriumRestatement
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply